The present study investigated the prognostic value of EGFR and EGFR ligands in the serum of 311 patients with early-stage breast cancer and demonstrated significantly shorter survival in patients with low pretreatment levels of either S-EGFR or S-HBEGF. Here, EGFR is linked to breast cancer.